Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG

(EUZ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Eckert & Ziegler Strahlen- und Medizintechnik AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

09/23/2021 | 09:09am EDT

DGAP Voting Rights Announcement: Eckert & Ziegler Strahlen- und Medizintechnik AG Eckert & Ziegler Strahlen- und Medizintechnik AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 2021-09-23 / 15:08 Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

Notification of Major Holdings 1. Details of issuer

 
 
 Name:                          Eckert & Ziegler Strahlen- und Medizintechnik AG 
 
 Street:                        Robert-Rössle-Str.10 
 
 Postal code:                   13125 
 
 City:                          Berlin 
                                Germany 
 
 Legal Entity Identifier (LEI): 391200EUDABLUKXCKG48 
 2. Reason for notification 
 
 
 X             Acquisition/disposal of shares with voting rights 
 
               Acquisition/disposal of instruments 
 
               Change of breakdown of voting rights 
 
 X             Other reason: 
               acting in concert 
 3. Details of person subject to the notification obligation 
 
 
 Legal entity: JPMorgan Asset Management (UK) Limited 
 City of registered office, country: London, United Kingdom 
 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3. 
 
 
 
 5. Date on which threshold was crossed or reached: 
 
 
 21 Sep 2021 
 6. Total positions 
 
 
                       % of voting rights % of voting rights through     Total of 
                       attached to shares                instruments    both in %        Total number of voting rights 
                          (total of 7.a.)   (total of 7.b.1 + 7.b.2)      (7.a. +             pursuant to Sec. 41 WpHG 
                                                                            7.b.) 
 
 New                               4.49 %                     0.96 %       5.46 %                             21171932 
 
 Previous                          5.18 %                     0.76 %       5.93 %                                    / 
 notification 
 7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG) 
 
 
 ISIN                    Absolute                        In % 
 
                       Direct       Indirect         Direct       Indirect 
               (Sec. 33 WpHG) (Sec. 34 WpHG) (Sec. 33 WpHG) (Sec. 34 WpHG) 
 
 DE0005659700               0         951181         0.00 %         4.49 % 
 
 Total                    951181                        4.49 % 
 b.1. Instruments according to Sec. 38 (1) no. 1 WpHG 
 
 
 Type of instrument           Expiration or maturity   Exercise or conversion           Voting rights Voting rights in 
                              date                     period                                absolute                % 
 
 Right to recall shares lent                                                                   203759           0.96 % 
 out 
 
                                                       Total                                   203759           0.96 % 
 b.2. Instruments according to Sec. 38 (1) no. 2 WpHG 
 
 
 Type of        Expiration or maturity Exercise or conversion  Cash or physical            Voting rights  Voting rights 
 instrument     date                   period                  settlement                       absolute           in % 
 
                                                                                                       0         0.00 % 
 
                                                               Total                                   0         0.00 % 
 8. Information in relation to the person subject to the notification obligation 
 
 
 X             Person subject to the notification obligation is not controlled nor does it control any other 
               undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.). 
 
               Full chain of controlled undertakings starting with the ultimate controlling natural person or legal 
               entity: 
 
 
 
 Name               % of voting rights (if at   % of voting rights through instruments (if  Total of both (if at least 
                            least 3% or more)                         at least 5% or more)                 5% or more) 
 
 
 9. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting: 
 
 
  Proportion of voting rights Proportion of instruments Total of both 
 
                            %                         %             % 
 10. Other explanatory remarks: 
 
 
 
 Date 
 
 
 23 Sep 2021 
 

-----------------------------------------------------------------------------------------------------------------------

2021-09-23 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

-----------------------------------------------------------------------------------------------------------------------

Language:     English 
Company:      Eckert & Ziegler Strahlen- und Medizintechnik AG 
              Robert-Rössle-Str.10 
              13125 Berlin 
              Germany 
Internet:     www.ezag.de 
 
End of News   DGAP News Service 
=------------ 

1235642 2021-09-23

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1235642&application_name=news

(END) Dow Jones Newswires

September 23, 2021 09:08 ET (13:08 GMT)

All news about ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
10/11ECKERT & ZIEGLER STRAHLEN UND MEDIZI : & Ziegler Acquires 53,000 Square Feet Facility for ..
PU
10/11ECKERT & ZIEGLER STRAHLEN UND MEDIZI : & Ziegler Acquires 53,000 Square Feet Facility for ..
EQ
10/11PRESS RELEASE : Eckert & Ziegler Acquires 53,000 Square Feet Facility for Expansion of Con..
DJ
09/30Eckert & Ziegler Strahlen- und Medizintechnik AG english
DJ
09/28ECKERT & ZIEGLER : Hauck & Aufhauser reaffirms its Buy rating
MD
09/28ECKERT & ZIEGLER STRAHLEN UND MEDIZI : Hauck & Aufhäuser
PU
09/27ECKERT & ZIEGLER STRAHLEN UND MEDIZI : Nantes University Hospital Doses First Patients wit..
PU
09/27ECKERT & ZIEGLER STRAHLEN UND MEDIZI : Nantes University Hospital Doses First Patients wit..
EQ
09/27PRESS RELEASE : Nantes University Hospital Doses First Patients with Eckert & Ziegler's No..
DJ
09/23ECKERT & ZIEGLER STRAHLEN- UND MEDIZ : Release according to Article 40, Section 1 of the W..
DJ
More news
Analyst Recommendations on ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
More recommendations
Financials
Sales 2021 180 M 209 M 209 M
Net income 2021 26,9 M 31,2 M 31,2 M
Net cash 2021 96,9 M 113 M 113 M
P/E ratio 2021 91,3x
Yield 2021 0,37%
Capitalization 2 517 M 2 920 M 2 922 M
EV / Sales 2021 13,5x
EV / Sales 2022 10,6x
Nbr of Employees 814
Free-Float 67,0%
Chart ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
Duration : Period :
Eckert & Ziegler Strahlen- und Medizintechnik AG Technical Analysis Chart | EUZ | DE0005659700 | MarketScreener
Technical analysis trends ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 119,60 €
Average target price 172,00 €
Spread / Average Target 43,8%
EPS Revisions
Managers and Directors
Andreas Eckert Chairman-Executive Board
Wolfgang Maennig Chairman-Supervisory Board
Helmut Grothe Vice Chairman-Supervisory Board
Albert Rupprecht Member-Supervisory Board
Edgar Löffler Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG166.73%2 879
JOHNSON & JOHNSON2.49%424 619
ROCHE HOLDING AG16.59%339 442
NOVO NORDISK A/S54.22%234 792
PFIZER, INC.12.71%232 621
ELI LILLY AND COMPANY40.89%215 657